BiomX Inc.
PHGE$7M
Micro CapNASDAQBiological Products, (No Diagnostic Substances)🇺🇸North AmericaDOVER
Drugs in Pipeline
2
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Mar 15, 2026
11dMarket Overview
Stock performance and key metrics
PHGE News
Catalyst Timeline
1 upcoming, 0 past
Phase 2Next
BX004 Phase 2 Results Expected
March 2026~EstimatedBX00463
Primary completion for BX004 trial (NCT06998043) in Chronic Pseudomonas Aeruginosa Infection
SourceRegulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply